Pfizer-BioNTech COVID-19 Vaccine booster authorized for select populations
by Press Release from Outbreak News Today on (#5PWSJ)
By NewsDesk @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years [...]
The post Pfizer-BioNTech COVID-19 Vaccine booster authorized for select populations appeared first on Outbreak News Today.